Insider trading

Period: 120 months Stock: REPL Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

82 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

82 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

82 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

82 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
82 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
82 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

82 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Aug 2026
Xynos Konstantinos Chief Medical Officer
Sold at will
$148.47K 11,447 at 12.97
4.9%
Not planned
10 Aug 2026
Schwendenman Andrew Chief Accounting Officer
Sold at will
$98.99K 7,632 at 12.97
7.1%
Not planned
1 Jun 2026
Sarchi Christopher Chief Commercial Officer
Sold on a plan
$110.88K 12,000 at 9.24
6.2%
Planned (10b5-1)
18 May 2026
Xynos Konstantinos Chief Medical Officer
Sold at will
$71.24K 14,023 at 5.08
5.6%
Not planned
18 May 2026
Sarchi Christopher Chief Commercial Officer
Sold at will
$43.82K 8,626 at 5.08
4.3%
Not planned
18 May 2026
Schwendenman Andrew Chief Accounting Officer
Sold at will
$40.10K 7,894 at 5.08
6.9%
Not planned
2 Apr 2026
Sarchi Christopher Chief Commercial Officer
Sold on a plan
$52.07K 6,500 at 8.01
4.1%
Planned (10b5-1)
17 Nov 2025
Xynos Konstantinos Chief Medical Officer
Sold at will
$65.96K 7,248 at 9.10
4.9%
Not planned
17 Nov 2025
Sarchi Christopher Chief Commercial Officer
Sold at will
$47.39K 5,208 at 9.10
4.1%
Not planned
20 May 2025
Xynos Konstantinos Chief Medical Officer
Sold at will
$64.09K 7,952 at 8.06
5.1%
Not planned
20 May 2025
Sarchi Christopher Chief Commercial Officer
Sold at will
$30.18K 3,749 at 8.05
2.8%
Not planned
20 May 2025
Schwendenman Andrew Chief Accounting Officer
Sold at will
$26.46K 3,287 at 8.05
4.6%
Not planned
18 Nov 2024
Xynos Konstantinos Chief Medical Officer
Sold at will
$78.11K 7,246 at 10.78
6.2%
Not planned
18 Nov 2024
Sarchi Christopher Chief Commercial Officer
Sold at will
$56.13K 5,207 at 10.78
5.6%
Not planned
7 Jun 2024
Xynos Konstantinos Chief Medical Officer
Sold on a plan
$119.11K 15,881 at 7.50
11.9%
Planned (10b5-1)
16 May 2024
Astley-Sparke Philip Executive Chairman
Sold at will
$245.39K 37,928 at 6.47
2.5%
Not planned
16 May 2024
Love Colin Chief Operating Officer
Sold at will
$113.97K 17,615 at 6.47
2.2%
Not planned
16 May 2024
Xynos Konstantinos Chief Medical Officer
Sold at will
$41.19K 6,367 at 6.47
4.6%
Not planned
16 May 2024
Schwendenman Andrew Chief Accounting Officer
Sold at will
$14.87K 2,298 at 6.47
5.7%
Not planned
16 May 2024
Sarchi Christopher Chief Commercial Officer
Sold at will
$14.35K 2,218 at 6.47
2.3%
Not planned
16 Nov 2023
Xynos Konstantinos Chief Medical Officer
Sold at will
$79.86K 7,313 at 10.92
6.1%
Not planned
16 Nov 2023
Sarchi Christopher Chief Commercial Officer
Sold at will
$57.38K 5,255 at 10.92
6.8%
Not planned
12 Sep 2023
Esposito Pamela Chief Business Officer
Sold on a plan
$6.00K 300 at 20.00
0.1%
Planned (10b5-1)
11 Sep 2023
Esposito Pamela Chief Business Officer
Sold on a plan
$107.21K 5,358 at 20.01
2.0%
Planned (10b5-1)
22 Aug 2023
Esposito Pamela Chief Business Officer
Sold on a plan
$372.19K 18,600 at 20.01
6.6%
Planned (10b5-1)
11 Aug 2023
Esposito Pamela Chief Business Officer
Sold on a plan
$28.00K 1,400 at 20.00
0.5%
Planned (10b5-1)
10 Jul 2023
Esposito Pamela Chief Business Officer
Sold on a plan 2×
$431.54K 20,000 at 21.58
7.1%
Planned (10b5-1)
13 Jun 2023
Lewis Tanya Chief Dev. Op. Officer
Sold on a plan 2×
$309.39K 12,860 at 24.06
8.7%
Planned (10b5-1)
13 Jun 2023
Patel Sushil Chief Strategy Officer
Sold on a plan 2×
$137.01K 5,698 at 24.04
3.7%
Planned (10b5-1)
16 May 2023
Patel Sushil Chief Strategy Officer
Sold at will
$281.13K 15,575 at 18.05
9.2%
Not planned
16 May 2023
Lewis Tanya Chief Dev. Op. Officer
Sold at will
$220.34K 12,207 at 18.05
7.6%
Not planned
16 May 2023
Love Colin Chief Operating Officer
Sold at will
$194.49K 10,775 at 18.05
1.3%
Not planned
16 May 2023
Coffin Robert President & Chief R&D Officer
Sold at will
$141.89K 7,861 at 18.05
0.4%
Not planned
16 May 2023
Esposito Pamela Chief Business Officer
Sold at will
$107.69K 5,966 at 18.05
2.2%
Not planned
16 May 2023
Xynos Konstantinos Chief Medical Officer
Sold at will
$13.92K 771 at 18.05
0.6%
Not planned
9 Dec 2022
Esposito Pamela Chief Business Officer
Sold, plan not stated
$375.45K 15,000 at 25.03
6.1%
16 May 2022
Patel Sushil Chief Commercial Officer
Sold, plan not stated
$155.92K 10,687 at 14.59
7.6%
16 May 2022
Love Colin Chief Operating Officer
Sold, plan not stated
$92.27K 6,324 at 14.59
0.8%
16 May 2022
Coffin Robert President & Chief R&D Officer
Sold, plan not stated
$83.70K 5,737 at 14.59
0.3%
16 May 2022
Lewis Tanya Chief Dev. Op Officer
Sold, plan not stated
$79.85K 5,473 at 14.59
4.3%
16 May 2022
Esposito Pamela Chief Business Officer
Sold, plan not stated
$51.17K 3,507 at 14.59
1.5%
18 Oct 2021
Love Colin Chief Operating Officer
Sold, plan not stated
$375.99K 12,711 at 29.58
1.7%
15 Oct 2021
Love Colin Chief Operating Officer
Sold, plan not stated 2×
$525.90K 17,289 at 30.42
2.2%
15 Sep 2021
Love Colin Chief Operating Officer
Sold, plan not stated
$936.90K 30,000 at 31.23
3.7%
16 Aug 2021
Love Colin Chief Operating Officer
Sold, plan not stated 2×
$898.03K 30,000 at 29.93
3.6%
5 Aug 2021
Esposito Pamela Chief Business Officer
Sold, plan not stated
$905.32K 25,800 at 35.09
10.9%
4 Aug 2021
Esposito Pamela Chief Business Officer
Sold, plan not stated
$147.00K 4,200 at 35.00
2.0%
21 Jul 2021
Esposito Pamela Chief Business Officer
Sold, plan not stated
$415.89K 12,538 at 33.17
5.6%
20 Jul 2021
Esposito Pamela Chief Business Officer
Sold, plan not stated
$160.69K 4,862 at 33.05
2.3%
15 Jul 2021
Love Colin Chief Operating Officer
Sold, plan not stated
$960.60K 30,000 at 32.02
3.5%
Showing 1–50 of 82. Page 1 of 2 Older →